Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the ability of the lay end user to understand the information contained in the User's Guide; to correctly identify patients who are suitably qualified to receive treatment; and to correctly administer the treatment with the Erchonia ZERONA® Z6 for circumference reduction of the waist, hips and thighs in an over-the-counter setting.


Clinical Trial Description

The Erchonia ZERONA® Z6 is a low level laser light therapy device that has been approved by the United States Food and Drug Administration (FDA) for use by licensed medical professionals to help to reduce the circumference of the hips, waist and thighs.

This study is to see if the Erchonia ZERONA® Z6 can be used by lay (non-medical professional) people to treat others to help to reduce the circumference of the hips, waist and thighs. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02167867
Study type Interventional
Source Erchonia Corporation
Contact
Status Completed
Phase N/A
Start date July 2014
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT00738426 - Study of Low Level Laser Therapy for Body Contouring N/A
Completed NCT01993238 - Evaluation of Procedural Analgesia for Liposonix Treatment N/A
Not yet recruiting NCT04167215 - Aesthetic Analysis of Gluteal Deformity After Weight Loss and Assessment the Role of Autologous Tissue Augmentation for Gluteal Contouring N/A
Completed NCT01376037 - Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference N/A
Completed NCT00399854 - Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring Phase 4
Completed NCT05771259 - Body Contouring After Bariatric Surgeries in Jordan
Completed NCT01292538 - Study of the Effectiveness of Green Diode Laser Light on Body Shaping N/A
Terminated NCT00399828 - Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite Phase 4